Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine wound infusion after liver resection
NCT01890408Phase 2Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2013
- Primary completion
- Feb 2014
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by Assistance publique - Hôpitaux de Paris. Started Nov 2013; status: terminated.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT01890408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01890408.